Published in Arch Gerontol Geriatr on April 15, 2013
Anosognosia in people with cognitive impairment: association with cognitive deficits and behavioral disturbances. Dement Geriatr Cogn Dis Extra (2015) 0.77
Awareness, apathy, and depression in Alzheimer's disease and mild cognitive impairment. Brain Behav (2017) 0.75
Ischemic preconditioning ameliorates excitotoxicity by shifting glutamate/gamma-aminobutyric acid release and biosynthesis. J Neurosci Res (2005) 1.16
The thalamus as the generator and modulator of EEG alpha rhythm: a combined PET/EEG study with lorazepam challenge in humans. Neuroimage (2004) 1.14
Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study. Neurobiol Aging (2007) 1.10
Association of serotonin transporter promoter gene polymorphism with violence: relation with personality disorders, impulsivity, and childhood ADHD psychopathology. Behav Sci Law (2004) 1.07
Detection of changed regional cerebral blood flow in mild cognitive impairment and early Alzheimer's dementia by perfusion-weighted magnetic resonance imaging. Neuroimage (2007) 1.04
The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia. Psychiatry Res (2010) 0.93
Intake of copper has no effect on cognition in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial. J Neural Transm (Vienna) (2008) 0.89
Single particle detection of Abeta aggregates associated with Alzheimer's disease. Biochem Biophys Res Commun (2007) 0.88
Cognitive decline correlates with low plasma concentrations of copper in patients with mild to moderate Alzheimer's disease. J Alzheimers Dis (2005) 0.87
Quantitative EEG in progressing vs stable mild cognitive impairment (MCI): results of a 1-year follow-up study. Int J Geriatr Psychiatry (2008) 0.85
Serotonin syndrome as a result of fluoxetine in a patient with tramadol abuse: plasma level-correlated symptomatology. J Clin Psychopharmacol (2002) 0.84
Epidemiology, symptoms, and treatment characteristics of hyponatremic psychiatric inpatients. J Clin Psychopharmacol (2013) 0.83
Transient reduction of spontaneous neuronal network activity by sublethal amyloid beta (1-42) peptide concentrations. J Neural Transm (Vienna) (2009) 0.82
Blood biomarkers of osteoporosis in mild cognitive impairment and Alzheimer's disease. J Neural Transm (Vienna) (2009) 0.82
Can an early weight management program (WMP) prevent olanzapine (OLZ)-induced disturbances in body weight, blood glucose and lipid metabolism? Twenty-four- and 48-week results from a 6-month randomized trial. World J Biol Psychiatry (2011) 0.79
Multielectrode array analysis of cerebrospinal fluid in Alzheimer's disease versus mild cognitive impairment: a potential diagnostic and treatment biomarker. Biochem Biophys Res Commun (2013) 0.79
Anterior limbic alpha-like activity: a low resolution electromagnetic tomography study with lorazepam challenge. Clin Neurophysiol (2005) 0.78
[Integrating patients with dementia and anosognosia into community care by a psychogeriatric consultation service]. Psychiatr Prax (2011) 0.77
An ultrasensitive assay for diagnosis of Alzheimer's disease. Rejuvenation Res (2008) 0.76
Reduced benefit from mnemonic strategies in early-stage Alzheimer's disease: a brief testing-the-limits paradigm for clinical practice. J Neurol (2010) 0.76
The stamp of ancestry: roots of behavioral and neuronal impairment in adulthood. Exp Neurol (2006) 0.75
[Treating dementia: start early and continue along the process]. MMW Fortschr Med (2010) 0.75
Amyloid beta 1-42 in cerebrospinal fluid is associated with cognitive plasticity. Psychiatry Res (2011) 0.75
Repressive Coping Does Not Contribute to Anosognosia in First-Diagnosis Patients With Alzheimer Disease. Alzheimer Dis Assoc Disord (2016) 0.75
Resumption of food and fluid intake in Alzheimer's disease with severe apathy following intravenous citalopram. Psychiatry Clin Neurosci (2012) 0.75
Pharmacotherapy of generalized anxiety disorder: focus and update on pregabalin. Expert Rev Neurother (2013) 0.75